Posts in category

In Depth


PPI use is increasing, writes Ben Basger—but what is its role long term? Do you think that when doctors decide to block the production of stomach acid by using a …

Review submission quantities reveal a somewhat disparate and divided profession, says Joe Demarte, PSA national president The many submissions responding to the Discussion Paper released by the Review of Pharmacy …

Future hay fever seasons will be worse thanks to climate change Janet Davies, The University of Queensland and Paul Beggs, Macquarie University It’s now late spring, with summer just around …

The latest in research news, as gathered by Debbie Rigby Pharmacokinetics and pharmacodynamics of sofosbuvir and ledipasvir for the treatment of hepatitis This article reviews the pharmacokinetic and pharmacodynamic properties …

Prescribing shouldn’t be our only focus when it comes to antibiotic resistance, writes Oscar Klass During Antibiotic Awareness Week the pharmacy profession will be reminded of the importance of antibiotics—how …

Health Check: are cosmetics containing Vitamin A safe during pregnancy? Ian Musgrave, University of Adelaide Cosmetics promise us many things, but could certain types of skin-care products containing vitamin A …

In the third of a series of interviews with the top five of our list of 10 Women of Influence in pharmacy, we speak to community pharmacy owner Elise Apolloni Do you …

Discount chemists are cheapening the quality of pharmacy along with the price Greg Kyle, Queensland University of Technology Every day, more discount pharmacy stores and chains are opening and assaulting …

With community pharmacy now directly involved in dispensing antiretrovirals, it’s more important than ever that pharmacists are up to speed on HIV, writes Louis Roller The acquired immune deficiency syndrome …

The launch of the Pharmacy Diabetes Screening Trial is a key step in progressing the Pharmacy Trial Program (PTP), says David Quilty, Pharmacy Guild executive director It is now 17 …

By Pence’s reasoning there are many other diseases that “do not kill”, writes Simon Chapman from the University of Sydney Simon Chapman, University of Sydney US Vice President elect Mike …

Debbie Rigby presents the latest in research news Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation In ARISTOTLE study, non-major bleeding was common and substantially less frequent …